Similar articles

• The evaluation of hypophysial response to thyrotrophin-releasing hormone (TRH) in patients affected by chronic liver disease.

  Fresco G, Fontana B, Biggi A, Curti G, Santaniello B, Savarino V. Fresco G, et al. Arch Maragliano Patol Clin. 1980;36:1-6. Arch Maragliano Patol Clin. 1980. PMID: 6807216 No abstract available.
• [Syndromes of inappropriate responses to Thyreoliberin VUFB in diseases of the thyroid gland].

  Nedvídková J, Kasafírek E, Felt V. Nedvídková J, et al. Vnitr Lek. 1980;26(12):1214-9. Vnitr Lek. 1980. PMID: 6782752 Czech. No abstract available.
• Abnormalities of thyrotrophin secretion and clinical implications of the thyrotrophin releasing hormone stimulation test.

  Lamberg BA, Gordin A. Lamberg BA, et al. Ann Clin Res. 1978;10(3):171-83. Ann Clin Res. 1978. PMID: 102236 Review. No abstract available.
• [Follow-up studies of patients with negative TRH test and normal thyroid hormone levels].

  Döge H, Hübner O, Kempe K, Riedel A, Ortweiler W. Döge H, et al. Z Gesamte Inn Med. 1993 Aug;48(8):398-400. Z Gesamte Inn Med. 1993. PMID: 8379222 German.
• [Etiology and diagnosis of Basedow's disease].

  Nakai T. Nakai T. Rinsho Byori. 1984 Jan;Spec No 58:120-9. Rinsho Byori. 1984. PMID: 6088843 Review. Japanese. No abstract available.